Fig. 1From: Cost-utility analysis of palonosetron in the antiemetic regimen for cisplatin-containing highly emetogenic chemotherapy in JapanDecision tree for cost-effectiveness analysis. PALO: palonosetron; GRA: granisetronBack to article page
